De-oiled Lecithin Market By Source (Soy, Sunflower, Rapeseed, Others); By Application (Food & Beverage, Pharmaceuticals, Animal Feed, Nutraceuticals, Personal Care); By Form (Powder, Granules); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

De-oiled Lecithin Market - Concentrated Phospholipid Ingredients Powering Clean-Label Emulsification and Dry Formulation Innovation – (Updated On: 13-Aug-2026)

The Global De-oiled Lecithin Market was valued at USD 351.23 million in 2025 and is projected to reach USD 542.22 million by 2032, expanding at a CAGR of 6.4% during 2026–2032. Food & beverage remains the largest application, soy is the leading source, powder dominates by form, and Asia-Pacific holds the largest regional position.

 

De-oiled lecithin is a high-purity phospholipid ingredient obtained from soybeans, sunflowers, or other natural oilseeds by removing most of the neutral oil fraction. This process produces a concentrated, fat-free emulsifier widely used across food, pharmaceutical, and cosmetic industries due to its plant-based origin and clean-label appeal. It is increasingly preferred as manufacturers shift toward natural alternatives that support healthier and more transparent product formulations.

 

Demand is rising rapidly due to the global clean-label movement, where consumers actively avoid synthetic emulsifiers in favor of recognizable plant-derived ingredients. The expansion of vegan, dairy-free, and plant-based food categories further strengthens its role in improving texture, stability, and mouthfeel. In addition, its high purity supports advanced pharmaceutical and nutraceutical applications, including liposomal drug delivery systems and supplements designed to enhance nutrient absorption. Superior handling characteristics and long shelf stability further reinforce its growing adoption across multiple high-value industries.

 

What Is Driving the Transformation of the De-Oiled Lecithin Market?

The de-oiled lecithin market is undergoing a significant transformation as manufacturers shift toward new plant-based sources beyond traditional soy. Growing consumer preference for allergen-free and non-GMO ingredients is accelerating demand for sunflower and rapeseed-derived lecithin powders, which are increasingly used in food, nutraceutical, and industrial formulations. At the same time, advancements in refining technology have enabled the production of highly purified lecithin with nearly all triglycerides and oils removed, resulting in a free-flowing powder or granule containing 95% or more phospholipids. This higher concentration improves functional efficiency while supporting cleaner label requirements across global markets.

Another key development shaping the industry is improved dispersion performance. Modern de-oiled lecithin dissolves and integrates rapidly into water-based systems, offering superior mixing compared to traditional liquid lecithin. Its neutral color and clean taste further enhance its suitability for sensitive applications such as beverages, bakery mixes, and dietary supplements. These combined improvements in source diversification, purity, and functionality are positioning de-oiled lecithin as a preferred emulsifier and stabilizer in next-generation formulations, supporting its expanding role in high-performance and health-focused product development.

 

Which De-oiled Lecithin Sources Are Gaining Importance?

Soy retains the largest position because soybean crushing produces a substantial and established stream of crude lecithin for further processing. It accounted for 48.0% of the market, or USD 168.59 million, in 2025 and is forecast to reach USD 238.58 million by 2032 at a 5.09% CAGR. U.S. soybean production is forecast at a record 4.5 billion bushels in 2026/27, maintaining a large raw-material base for soy-derived lecithin.

Manufacturers choosing sunflower lecithin are often trying to remove soy from a formulation while retaining similar emulsification and dispersion functions. The segment represented 24.0% or USD 84.29 million in 2025 and is expected to reach USD 140.98 million by 2032 at a 7.62% CAGR. The FDA's 2026 GRAS record for sunflower lecithin covers use as an alternative lecithin source, emulsifier, surfactant, dispersing agent and nutritional ingredient, widening the documented food-use basis for sunflower-derived material in the U.S.

Rapeseed is becoming more relevant where food producers want another plant source beyond soy and sunflower. Revenue is modeled to rise from USD 63.22 million in 2025 to USD 108.44 million by 2032, making it the fastest-growing source at 8.01% CAGR. Primary-granulated rapeseed products introduced in 2025 show that this source is moving beyond conventional fluid lecithin into dry formats designed for easier handling and more consistent processing.

Other sources accounted for 10.0% or USD 35.12 million in 2025 and are projected to reach USD 54.22 million by 2032 at a 6.40% CAGR. Their opportunity lies in specialized formulations seeking different phospholipid profiles or alternatives to established oilseeds. Recent technical work on lecithin from niche oils such as camelina, flax, hemp and pumpkin seed reflects growing interest in less conventional botanical sources, although these remain much smaller than soy, sunflower and rapeseed.

 

Where Is De-oiled Lecithin Used Most?

Food & beverage remains the largest application at 44.0% and USD 154.54 million in 2025, with revenue projected to reach USD 216.89 million by 2032 at a 4.96% CAGR. Bakery producers use de-oiled lecithin to improve mixing and dough handling, while instant powders require better wetting and dispersion. In confectionery, its role extends to viscosity and fat distribution. A recent industrial bakery project also evaluated hydrolyzed lecithin as a replacement for DATEM, illustrating how formulation changes can create recurring lecithin use once a recipe is approved for production.

Pharmaceutical demand is more closely linked to formulation performance than to bulk emulsification. The segment is forecast to increase from USD 63.22 million in 2025 to USD 108.44 million by 2032 at an 8.01% CAGR. Phospholipids are being investigated in oral and topical delivery systems where solubilization, encapsulation or membrane-like structures are required. Recent studies continue to use soy lecithin in lipid-based micelles and other drug-delivery systems, maintaining a technical pathway for pharmaceutical-grade phospholipid ingredients.

Animal feed has the highest application CAGR at 8.32%, moving from USD 52.68 million to USD 92.18 million by 2032. Here, additional use comes from phospholipid supplementation and lipid utilization rather than food texture. A 2024 dairy study tested 74.5 g of de-oiled soy lecithin and 133.5 g of hydrolyzed sunflower lecithin, while a 2026 Atlantic salmon study evaluated soybean-lecithin phospholipids for growth and lipid metabolism. These trials provide direct technical evidence for continued use of lecithin in specialized feed formulations.

Nutraceuticals generated USD 45.66 million in 2025 and are projected to reach USD 70.49 million by 2032 at a 6.40% CAGR. Dry lecithin is suited to supplements because concentrated phospholipids can be incorporated into powders, capsules and other nutrition formats without the handling issues of fluid lecithin. Research on soy-derived lysophosphatidylcholine and lysolecithin also shows continuing interest in lecithin-derived choline delivery, although these more specialized materials extend beyond standard de-oiled grades.

Personal care is expected to increase from USD 35.12 million to USD 54.22 million at a 6.40% CAGR. Formulators use phospholipids where emulsification or lipid-based delivery is required in creams, gels and skin-delivery systems. Recent research has examined hydrogenated plant lecithins for cosmetic formulations and lecithin-based nanovesicles for dermal delivery, keeping specialty lecithin relevant to higher-value personal-care development.

 

Why Does Powder Lead While Granules Grow Faster?

Powder represented 66.0% of the market and USD 231.81 million in 2025, with revenue forecast to reach USD 325.33 million at a 4.96% CAGR. Its advantage is straightforward incorporation into premixes and powdered products. Removing much of the oil increases phospholipid concentration while avoiding the pumping and sticky handling associated with fluid lecithin, making powder practical for high-throughput dry blending.

Granules are gaining preference where controlled feeding, flow and clean handling matter more during production. Valued at USD 84.29 million in 2025, the segment is projected to reach USD 151.82 million by 2032 at an 8.77% CAGR. Sternchemie's 2025 introduction of primary-produced sunflower and rapeseed granules responds directly to the need for consistent granule quality and wider botanical choice, giving processors alternatives to conventional soy-based granules.

Other forms remain small but record the fastest form-based growth, rising from USD 35.12 million to USD 65.07 million at a 9.21% CAGR. These products are most relevant where a standard powder or granule does not provide the required particle behavior, dispersibility or phospholipid composition. Their growth therefore comes from application-specific formulation rather than replacement of mainstream powder.

 

Why Does Asia-Pacific Lead the Regional Market?

Asia-Pacific held the largest regional position at 32.0% or USD 112.39 million in 2025 and is projected to reach USD 189.78 million by 2032 at a 7.77% CAGR. India has a substantial processing base for soy and other oilseeds, while domestic producers serve food, nutraceutical and export applications. Additional Indian de-oiled lecithin capacity announced for output from 2026 indicates that processors are increasing dry-lecithin availability in response to customer requirements.

North America accounted for 30.0% and USD 105.37 million in 2025, reaching an estimated USD 151.82 million by 2032 at a 5.36% CAGR. Local soybean crushing gives manufacturers ready access to soy lecithin, while record U.S. soybean and canola production forecasts improve the feedstock base for both conventional and alternative-source products. The region also has commercial availability of de-oiled powders and granules for bakery, beverages, confectionery and convenience foods.

Europe's 27.0% share, worth USD 94.83 million in 2025, is projected to become USD 135.56 million by 2032 at a 5.24% CAGR. Demand is increasingly differentiated by botanical origin, non-GM sourcing and allergen considerations. Soybean products fall within EU allergen-information requirements except for specified exemptions that do not generally cover lecithin, encouraging some manufacturers to evaluate sunflower or rapeseed alternatives when reformulating products.

Latin America is smaller at USD 17.56 million in 2025, but its 7.86% CAGR is the highest regional rate, taking revenue to USD 29.82 million by 2032. A direct signal comes from Brazil, where Cargill began lecithin production at its Ponta Grossa facility in May 2025 to expand its soybean-derived portfolio and serve animal-nutrition demand. Local production shortens the supply route between soybean processing and regional feed applications.

The Middle East & Africa market is forecast to rise from USD 21.07 million to USD 35.24 million at a 7.62% CAGR. Demand remains concentrated in food, feed, pharmaceutical and nutrition formulations that use imported or regionally distributed specialty ingredients. South Africa already has access to powdered and granulated de-oiled soy, sunflower and rapeseed lecithins, while local oilseed processors also recover lecithin from canola and other crops.

 

How Do Food Safety and Compliance Requirements Affect De-oiled Lecithin Demand?

In the United States, lecithin is listed under 21 CFR 184.1400 as a GRAS food substance for specified conditions of use. Food manufacturers therefore require grades that meet the relevant identity, purity and use conditions. Soy-derived lecithin also creates a labeling consideration because FDA requires the soy source of a major allergen to be identified, with “lecithin (soy)” given as an explicit example. This makes documented soy grades necessary while also creating a clear reason to consider sunflower alternatives in soy-free formulations.

European food use operates under the EU food-additive framework, where lecithins are identified as E 322 and specifications are established through Regulation (EU) No 231/2012. Regulation (EU) No 1169/2011 separately places soybeans and their products within mandatory allergen-information rules, subject to listed exemptions. The practical effect is greater emphasis on source identification, specification control and documented non-soy alternatives when manufacturers want to change allergen declarations.

Asia-Pacific does not operate under one unified lecithin regulation. India regulates food additives through FSSAI's Food Products Standards and Food Additives framework, while Australia and New Zealand use Standard 1.3.1 and Schedule 15 of the Food Standards Code to govern permitted food additives and their conditions of use. These legal frameworks favor ingredients supplied with clear identity, food-grade specifications and application documentation rather than creating demand for lecithin indiscriminately.

Internationally, JECFA identifies lecithin as INS 322(i) and maintains food-additive specifications, while the Codex General Standard for Food Additives records permitted uses of lecithin. These are international reference frameworks rather than a single global legal requirement. They are commercially important for companies selling across several countries because common specifications can simplify technical qualification and documentation for export-oriented food applications.

 

How Is Competition Developing in the De-oiled Lecithin Market?

Competition centers on botanical choice, dry-format capability, processing consistency and access to crude lecithin. Large oilseed processors compete with specialist lecithin companies, while application-focused portfolios allow producers to address food, feed, nutrition and specialty formulations without relying on one source.

• Bunge positions BungeMaxx de-oiled soy lecithin in powder and granule formats for bakery, beverages, snacks and supplements. Its integration with soybean processing gives the company a direct route from oilseed crushing to higher-value dry lecithin.

• Cargill offers de-oiled powders and granules together with broader lecithin portfolios derived from soy, sunflower and rapeseed. Its Emulpur, Lecigran, Emultop and Lecimulthin ranges address functions including emulsification, wetting and dispersibility across food applications.

• Lasenor supplies de-oiled soy and sunflower lecithins and is expanding Indian production from 2026. Its portfolio also covers bakery, instant powders and other formulation-focused lecithin applications.

• Sternchemie differentiates through GM-free soy, sunflower and rapeseed lecithins. Its SternPur range adds primary-produced sunflower and rapeseed granules, strengthening its position in non-soy and granulated products.

• Sonic Biochem maintains de-oiled soy lecithin alongside sunflower lecithins and phospholipid ingredients for food, nutraceutical and healthcare applications. Its export presence makes it relevant to competition from India-based specialty lecithin producers.

The market is projected to add approximately USD 190.99 million in annual revenue between 2025 and 2032. Soy should retain scale, but faster growth in sunflower, rapeseed, granules, animal feed and pharmaceuticals will make source flexibility and application-specific dry formats increasingly important. The principal forecast risk remains the dependence of crude lecithin availability on oilseed crushing activity rather than lecithin demand alone.

 

Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 351.23 Million
Revenue Forecast in 2032	USD 542.22 Million
Overall Growth Rate	CAGR of 6.4% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Source, By Application, By Form, By Geography
By Source	Soy, Sunflower, Rapeseed, Others
By Application	Food & Beverage, Pharmaceuticals, Animal Feed, Nutraceuticals, Personal Care
By Form	Powder, Granules
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Brazil, Mexico, South Africa, UAE
Market Drivers	Rising clean-label ingredient demand and preference for plant-based emulsifiers; growing adoption of soy-free and non-GMO lecithin sources; increasing use in food, pharmaceutical, nutraceutical, and animal nutrition formulations
Customization Option	Available upon request